13 completed. 13 Phase 2, 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 13 |
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Sedation: new trials by email Literature Review of Sedation trials Research Report on Sedation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Esketamine Combined With Dexmedetomidine Sedation in Head MRI Examination of Children With Autism Spectrum Disorder low dos dexmedetomidine, high dos dexmedetomidine, dexmedetomidine and esketamine - Autism Spectrum Disorder, Dexmedetomidine | Phase 2 | Completed | Maternal and Child Health Hospital of Hubei Province | 300 | 2022-12-01 | 2024-10-09 |
| A Study Evaluating the Efficacy and Safety of HSK3486 for Sedation HSK3486 0.1-0.2 /0.3 mg / kg group, Propofol 0.5-1.0/1.5 mg/kg group - Sedation | Phase 2 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 39 | 2019-11-22 | 2022-05-27 |
| Propofol vs. Midazolam With Propofol for Sedative Endoscopy in Patients With Previous Paradoxical Reaction to Midazolam Propofol, Midazolam - Sedation, Endoscopy | Phase 2 | Completed | DongGuk University | 30 | 2018-10-19 | 2020-12-29 |
| Pharmacokinetics and Pharmacodynamics of Oral Transmucosal Dexmedetomidine. OTM Dexmedetomidine 1µg/ kg., OTM Dexmedetomidine 0.75µg/ kg., OTM Dexmedetomidine 0.5µg/ kg. - Sedation | Phase 2 / Phase 3 | Completed | Assiut University | 36 | 2017-04-05 | 2019-08-01 |
| Safety And Efficacy Of Dexmedetomidine Sedation In Intubated Mechanically Ventilated Infants With Respiratory Failure Dexmedetomidine 0.35µg/kg /h, Dexmedetomidine 0.5µg/kg /h - Sedation | Phase 2 / Phase 3 | Completed | Assiut University | 40 | 2016-12-01 | 2018-07-03 |
| A Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy Remimazolam Tosilate, Propofol - Sedation | Phase 2 | Completed | Jiangsu HengRui Medicine Co., Ltd. | 153 | 2016-11-01 | 2017-09-08 |
| Phase II Pharmacokinetic and Pharmacodynamic Study of DEX in Subjects Aged 12 Months Through <24 Months Dexmedetomidine - Sedation, Pain | Phase 2 | Completed | Hospira, now a wholly owned subsidiary of Pfizer | 5 | 2011-06-01 | 2015-07-24 |
| Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Pediatrics Ages ≥28 Weeks to ≤44 Weeks Gestational Age Midazolam, Fentanyl/Morphine, Dexmedetomidine - Sedation | Phase 2 / Phase 3 | Completed | Hospira, now a wholly owned subsidiary of Pfizer | 36 | 2010-07-01 | 2015-08-13 |
| Multiple Dose Safety and Efficacy Study Evaluating CNS 7056 Versus Midazolam in Patients Undergoing Colonoscopy A. CNS 7056, B. CNS 7056, C. CNS 7056 - Sedation | Phase 2 | Completed | Paion UK Ltd. | 162 | 2010-05-01 | 2019-01-08 |
| A Study to Evaluate the Clinical Efficacy, Safety and Tolerability of ARX-F03 Sublingual Sufentanil/Triazolam NanoTab™ in Patients Undergoing an Elective Abdominal Liposuction Procedure Sublingual Sufentanil/Triazolam NanoTab™ (ARX-F03), Placebo NanoTab™ - Sedation, Anxiety | Phase 2 | Completed | Talphera, Inc | 40 | 2009-06-01 | 2014-06-25 |
| Dexmedetomidine Cardiovascular Safety in Pediatric Burn Patients Dexmedetomidine - Burns, Sedation | Phase 2 | Completed | Massachusetts General Hospital | 8 | 2007-07-16 | 2017-07-17 |
| Acute Neurological ICU Sedation Trial (ANIST) Fentanyl/Dexmedetomidine, Fentanyl/Propofol, Fentanyl - Sedation | Phase 2 | Completed | Johns Hopkins University | 35 | 2005-05-01 | 2019-05-16 |
| Clonidine-Remifentanil. Effect of the Combination on Acute Pain and Respiration in Healthy Volunteers Remifentanil+clonidine - Acute Pain, Respiration | Phase 1 / Phase 2 | Completed | Oslo University Hospital | 12 | 2005-02-01 | 2011-07-06 |
Pain (2) · Acute Pain (1) · Anxiety Disorders (1) · Autism Spectrum Disorder (1) · Burns (1) · Respiratory Aspiration (1)
Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Mental Disorders (2) · Child Development Disorders, Pervasive (1) · Neurodevelopmental Disorders (1) · Pain (1) · Pathologic Processes (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Wounds and Injuries (1)
Dexmedetomidine (7) · Propofol (3) · Fentanyl (2) · Midazolam (2) · Clonidine (1) · Esketamine (1) · Morphine (1) · Remifentanil (1) · remimazolam (1)
Assiut University (2) · Hospira, now a wholly owned subsidiary of Pfizer (2) · DongGuk University (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Johns Hopkins University (1) · Massachusetts General Hospital (1) · Maternal and Child Health Hospital of Hubei Province (1) · Oslo University Hospital (1) · Paion UK Ltd. (1) · Sichuan Haisco Pharmaceutical Group Co., Ltd (1) · Talphera, Inc (1)
United States (6) · China (3) · Egypt (2) · Guatemala (1) · Norway (1) · South Korea (1)
Constantinos Chrysostomou, MD (1) · Erik S Shank, MD (1) · Hala S Abdel-Ghaffar, MD (1) · Jon B Bergmann, Ass. Prof. (1) · Linli Yue, MD (1) · Marek Mirski, MD, PhD (1) · Pamela Palmer, M.D., PhD (1) · Saher A Mohamed, MD (1)
PMID 15460178, PMID 21926576, PMID 24238862, PMID 24893689, PMID 26363333, PMID 32889844, PMID 34924506, PMID 39455495